Browse by Clinical Topic:

Featured CME/CE Content:
neuroscienceCME Editors' Picks:

Applying Patient-Centered Pain Care to Practice: A Case of Chronic Pain and Opioid Use Disorder

Premiere Date: Friday, December 23, 2022

This activity offers CE credit for:

  1. ABIM (MOC)
  2. Family Physicians (AAFP)
  3. Medicine (accme)
  4. Nursing (ANCC)
  5. Pharmacy (acpe)
  6. Dentists (ADA CERP)
  7. PA (aapa)
  8. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Saturday, December 23, 2023
Note: Credit Is No Longer Available


Melissa Weimer, DO, MCR, FASAMMelissa Weimer, DO, MCR, FASAM (Moderator)
Associate Professor of Medicine and Public Health
Yale School of Medicine and Yale School of Public Health
Medical Director, Addiction Medicine Consult Service
Yale New Haven Hospital
New Haven, CT

Sudheer Potru, DO, FASAMSudheer Potru, DO, FASAM 
Director, Complex Pain Clinic
Atlanta VA Medical Center
Decatur, GA

Statement of Need

Patients taking prescription opioids to manage pain are at a heightened risk of developing opioid use disorder (OUD). This innate risk needs to be vigilantly monitored by health care providers (HCPs) and strategies must be in place to engage patients in treatment when OUD is confirmed. HCPs should be aware of the Diagnostic and Statistical Manual of Mental Disorders’ (DSM-5) criteria for the diagnosis of OUD as well as the risk factors and available risk assessments for OUD. Long-term exposure to opioid therapy causes psychological and neurological changes and practical guidance for safe and thoughtful tapering must be executed slowly to ensure patients’ safety. Additionally, clinicians must be up to date on naloxone prescribing regulations as well as community resources for the psychosocial treatment of OUD.

In this fourth and final installment of a REMS BriefCase series on pain management faculty will discuss the importance of recognizing the signs of OUD and how to intervene if red flags do appear. It is vital that clinicians prescribing opioids monitor their patients closely for OUD and are equipped with the tools needed to safely treat the disorder.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Utilize the DSM-5 criteria to identify and diagnose opioid use disorder (OUD) in patients prescribed opioids for acute and chronic pain. Develop strategies for engaging patients in treatment for OUD.

Financial Support

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please click here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).

Target Audience

Physicians, surgeons, dentists, PAs, NPs, nurse practitioners, and pharmacists

Credit Information

AAFP Credit (Family Physicians):
The AAFP has reviewed Applying Patient-Centered Pain Care to Practice: A Case of Chronic Pain and Opioid Use Disorder and deemed it acceptable for up to 0.50 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 12/31/2022 to 12/31/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Formats
Enduring activity

Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Weimer reports the following financial relationships:

Consultant: CVS Health and Path CCM, Inc.

Dr. Potru reports no financial relationships to disclose.

The following peer reviewer and CME Outfitters staff have no financial relationships:

  • Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer)
  • Thomas W. Heinrich, MD (planning committee)
  • Evan Luberger (planning committee)
  • Kellie Busby, PharmD (planning committee)
  • Kasey Brandt, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

  • Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

    Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


    Home      |      Register/Log In      |      Activities      |      Communities of Practice      |      About      |      Download